Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme (COGLI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01205334
Recruitment Status : Terminated (poor accrual)
First Posted : September 20, 2010
Last Update Posted : August 26, 2013
Texas Children's Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
The Methodist Hospital System
Information provided by (Responsible Party):
Nabil Ahmed, Baylor College of Medicine

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2012
  Actual Study Completion Date : March 2012
  Certification/Extension First Submitted : August 17, 2013